PRICE T ROWE ASSOCIATES INC /MD/
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 80255
BALTIMORE, MD
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$858,558,562
+$72,593,685 QoQ
Shares Held
1,728,421
-1.8% QoQ
Ownership
0.682%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#27
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. VRTX ranks #3 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $858,558,562 | 1,728,421 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $785,964,877 | 1,760,122 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,033,188,398 | 2,278,958 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,192,075,789 | 3,043,805 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,406,774,123 | 3,159,870 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,414,329,993 | 2,917,227 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $680,844,889 | 1,690,700 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $822,266,090 | 1,768,010 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,036,655,836 | 2,211,674 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,878,295,329 | 4,493,422 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,395,529,067 | 5,887,412 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $2,382,041,950 | 6,850,066 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,378,474,527 | 6,758,758 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,076,371,162 | 6,590,190 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,356,592,275 | 4,697,667 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,493,434,000 | 5,157,954 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,398,434,442 | 4,962,683 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,384,366,776 | 5,304,697 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,190,515,503 | 5,421,291 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,033,605,023 | 5,698,247 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,641,048,941 | 13,098,492 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,556,402,853 | 16,549,876 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,638,627,218 | 19,626,924 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,543,335,838 | 20,370,924 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,154,137,115 | 21,198,502 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,145,408,432 | 21,623,906 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||